Suma M Krishnan

4PUBLICATIONS
3CO-AUTHORS
Gene and molecular therapyCancer geneticsMedical devicesProperty law (excl. intellectual property law)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 12, 2025
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa.

M Peter Marinkovich, Amy S Paller, Shireen V Guide

|Feb 07, 2024
Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.

Arianna Tovar Vetencourt, Ibrahim Sayed-Ahmed, Jennifer Gomez

|Dec 14, 2022
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.

Shireen V Guide, Mercedes E Gonzalez, I Sinem Bağcı

Pageof 1